Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 5/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10802680 | 0.70 | CYP2C9 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19ELANE | |
| SCHEMBL9782570 | 0.69 | ALDH1A1 (0.47) | HTR2CALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL10803264 | 0.69 | CYP3A4 (0.41) | ALDH1A1CYP3A4CYP2C9CYP2C19ELANE | |
| SCHEMBL11453466 | 0.69 | CYP3A4 (0.42) | HTR2CALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL9782599 | 0.68 | ALDH1A1 (0.46) | ALDH1A1CYP3A4CYP2C9CYP2C19ELANE | |
| SCHEMBL563134 | 0.67 | HPGD (0.41) | HTR2CALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4052931 | 0.66 | HTR2C (0.72) | HTR2CALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL31316158 | 0.66 | HTR2C (0.72) | HTR2CALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL466107 | 0.66 | ALDH1A1 (0.66) | ALDH1A1CYP3A4HPGD | |
| SCHEMBL3682048 | 0.66 | ALDH1A1 (0.66) | ALDH1A1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011032192-A1 | SUBSTITUTED CLAVULANIC ACID | NABRIVA THERAPEUTICS AG (AT) | 2011-03-24 | — | — | WO | disclosed |